Dehaier Medical to Present at the CFA 2012 Cross-Continental Summit on Investment in Shanghai

BEIJING, May 17, 2012 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products, today announced that the Company will present at the CFA 2012 Cross-Continental Summit on Investment, to be held at the Shanghai Purple Mountain Hotel in Shanghai on May 18, 2012.

Dehaier's Chairman and CEO, Mr. Ping Chen, will present and participate in the "Health Care and Medical" panel discussion at 4:40 p.m. local time on Friday, May 18, 2012 and meet with investors throughout the day. Additional information on CFA and the conference (including Mr. Chen's full biography) can be found by visiting the association's website at http://www.cfasociety.org/china/ and clicking the appropriate links.

About Dehaier Medical Systems Ltd.

Dehaier is an emerging leader in the development, assembly, marketing and sale of medical products, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded medical devices and homecare medical products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (Italy), Welch Allyn (USA), HEYER (Germany), Timesco (UK), eVent Medical (US) and JMS (Japan). Dehaier's technology is based on six patents and five software copyrights; additionally Dehaier has two pending software copyrights and proprietary technology. More information may be found at http://www.dehaier.com.cn

Forward-looking Statements

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events, government approvals or performance, and underlying assumptions and other statements that are other than statements of historical facts, including in particular statements about Dehaier's attendance at the referenced summit. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, future developments in payment for and demand for medical equipment and services, implementation of and performance under the joint venture agreement by all parties, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

Contact Us

Dehaier Medical Systems Limited
Surie Liu
+86 10-5166-0080
lius@dehaier.com.cn

Dehaier Medical Systems Limited
Tina He
+86 10-5166-0080
hexw@dehaier.com.cn

The Equity Group Inc.
Katherine Yao
+86 10-6587-6435
kyao@equityny.com

In America

The Equity Group Inc.
Adam Prior
(212) 836-9606
aprior@equityny.com